XENE today
$42.10+$0.71 (+1.72%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bullish
1 hourStrong Bullish
15 minStrong Bullish
5 minStrong Bullish
Daily trend turns up above $39.92
Key levels
Resistance$46.99
Resistance$43.66
Support$41.05
Support$39.58
Latest news & SEC filings
EarningsXenon Pharmaceuticals Posts Q3 2026 Results
EarningsXenon Pharmaceuticals holds Q3 2026 earnings call
SEC FilingXenon Pharmaceuticals Inc. filed a report on a major company event (Form 8-K)
EarningsXenon Pharmaceuticals reports Q3 loss of $1.11 per share, beating $1.13 estimate
All XENE news →About Xenon Pharmaceuticals
Xenon Pharmaceuticals is a drug developer focused on the brain and nervous system. Its main experimental treatment, azetukalner, is being tested in late-stage trials for seizure disorders and mood conditions such as depression. The company also runs earlier research programs aimed at pain and other unmet medical needs. It is based in Canada and carries out activities in the United States.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
Xenon Pharmaceuticals Inc. (XENE)
What Is the Price Target for XENE?
SEPT Low Target
$46.00
SEPT Mid Target
$67.00
SEPT High Target
$90.00
Analyst Consensus
$67.00
Is XENE a Buy or Sell Right Now?
Thesis
- •Revenue growing -20.5% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for XENE.
Start Free Trial →Is XENE Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$67.00
27
Moat Score
NONE
2/9
Piotroski Score
32.5
Altman Z-Score
What Is Smart Money Doing with XENE?
Insider Signal
SELLING
2 buys / 13 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Kelly Thomas Patrick | officer | Buy | 7,500 | - | Oct 15, 2026 |
| Kelly Thomas Patrick | officer | Buy | 15,000 | $560K | Sep 30, 2026 |
| MORTIMER IAN | director officer | Buy | 30,000 | $1.1M | Sep 30, 2026 |
| Svoronos Dawn | director | Buy | 5,144 | $42K | Sep 1, 2026 |
| KENNEY CHRISTOPHER JOHN | officer | Sale | 6,368 | $383K | Aug 28, 2026 |
| KENNEY CHRISTOPHER JOHN | officer | Sale | 700 | $43K | Aug 28, 2026 |
| PATOU GARY | director | Sale | 1,322 | $70K | Jun 5, 2026 |
| Cannon Gillian | director | Sale | 1,190 | $63K | Jun 5, 2026 |
| GANNON STEVEN | director | Sale | 1,416 | $76K | Jun 1, 2026 |
| Svoronos Dawn | director | Sale | 1,416 | $76K | Jun 1, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →XENE Growth Story
Revenue YoY
-20.5%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-44.85%
FCF Growth YoY
-51.8%
Revenue Trend
ACCELERATING
Dark Pool Trades for XENE
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for XENE, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:45 | $42.10 | 11,406 | $$480K | BUY |
| 21:00:39 | $42.10 | 1,950 | $$82K | BUY |
| 21:00:39 | $42.10 | 1,803 | $$76K | BUY |
| 21:00:00 | $42.10 | 1,537 | $$65K | SELL |
| 20:58:42 | $42.12 | 1,347 | $$57K | BUY |
5 dark pool trades shown · $$760K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for XENE
PREVIEWSEPT Investing provides real-time options flow tracking for XENE, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $45 | Jan 15 | 65 | $$340 | 1 | SWEEP |
| CALL | $45 | Jan 15 | 65 | $$680 | 2 | SWEEP |
| CALL | $45 | Jan 15 | 65 | $$4080 | 12 | SWEEP |
| CALL | $45 | Jan 15 | 65 | $$340 | 1 | SWEEP |
| CALL | $45 | Jan 15 | 65 | $$340 | 1 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Xenon Pharmaceuticals Inc. (XENE) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →XENE — frequently asked questions
What is XENE stock price today?
Xenon Pharmaceuticals Inc. (XENE) is at $42.10, up 1.72% (+$0.71) at the Nov 11, 2026 close.
Why is XENE stock moving today?
Latest XENE news — Nov 9, 2026: Xenon Pharmaceuticals Posts Q3 2026 Results · Nov 9, 2026: Xenon Pharmaceuticals holds Q3 2026 earnings call
Why did XENE stock move on Nov 9, 2026?
Xenon Pharmaceuticals shares closed at $40.45, up 1.81% on volume of about 1.48 million shares, after the company reported a third-quarter loss of $1.11 per share that beat the $1.13 consensus estimate. The stock traded between a low of $38.59 and a high of $40.52 during the session.
What is the XENE price target?
The average analyst price target for XENE is $67.00, ranging from $46 to $90, based on 8 analysts.
What do analysts rate XENE?
Analyst ratings for XENE: 17 Buy, 1 Hold, 0 Sell — consensus Strong Buy.
Did XENE beat earnings?
XENE last reported on Nov 9, 2026: EPS -$1.11 vs -$1.13 expected — a beat of 1.8%.
Does XENE pay a dividend?
XENE does not currently pay a dividend.
What are XENE support and resistance levels?
Support: $41.05, $39.58, $37.15. Resistance: $43.66, $46.99, $50.91.
What are insiders doing with XENE?
Insider activity: SELLING, 2 buys and 13 sells in the last 90 days.
What is the latest news on XENE?
Nov 9, 2026: Xenon Pharmaceuticals Posts Q3 2026 Results · Nov 9, 2026: Xenon Pharmaceuticals holds Q3 2026 earnings call · Nov 9, 2026: Xenon Pharmaceuticals Inc. filed a report on a major company event (Form 8-K)